Increased arterial distensibility induced by the angiotensin‐converting enzyme inhibitor, lisinopril, in normotensive rats

1 We investigated possible structural correlates of the beneficial effect of chronic angiotensin‐converting enzyme inhibition (ACEI) with lisinopril on the aortic distensibility of normotensive rats. 2 Experiments were performed in young (4‐month old), normotensive, Wistar rats which received lisino...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 1994-02, Vol.111 (2), p.555-560
Hauptverfasser: Makki, Touria, Talom, Rabelais Tatchum, Niederhoffer, Nathalie, Amin, Fatiha, Tankosic, Pierre, Mertès, Paul‐Michel, Atkinson, Jeffrey
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 560
container_issue 2
container_start_page 555
container_title British journal of pharmacology
container_volume 111
creator Makki, Touria
Talom, Rabelais Tatchum
Niederhoffer, Nathalie
Amin, Fatiha
Tankosic, Pierre
Mertès, Paul‐Michel
Atkinson, Jeffrey
description 1 We investigated possible structural correlates of the beneficial effect of chronic angiotensin‐converting enzyme inhibition (ACEI) with lisinopril on the aortic distensibility of normotensive rats. 2 Experiments were performed in young (4‐month old), normotensive, Wistar rats which received lisinopril in their drinking water (0.9 or 9 mg kg−1 day−1) for 9 months. 3 Following ACEI treatment, rats were pithed and aortic pulse wave velocity was measured during the progressive rise in mean arterial blood pressure produced by i.v. infusion of the α1‐adrenoceptor agonist, phenylephrine. The slope of the regression line relating aortic pulse wave velocity to mean arterial blood pressure was taken as an index of aortic distensibility. Following this, the aorta was fixed in situ at a normotensive pressure level and histomorphometry was performed. We also measured the calcium content of the aortic wall by atomic absorption. 4 The lower dose of lisinopril failed to lower systolic arterial blood pressure (unanaesthetized rat) or mean arterial blood pressure (pithed rat). Chronic ACEI with the higher dose of lisinopril lowered both systolic arterial blood pressure (104 ± 6 mmHg, controls 133 ± 4 mmHg, unanaesthetized), and mean arterial blood pressure (27 ± 1 mmHg, controls 34 ± 2 mmHg, pithed). 5 Although the lower dose of lisinopril did not lower blood pressure, it did improve aortic distensibility as revealed by a fall in the slope relating aortic pulse wave velocity (Y) to mean arterial blood pressure (X). Values were 5.7 ± 0.7, 3.8 ± 0.6 and 2.7 ± 0.3 in controls, and in low and high ACEI groups, respectively. 6 Lisinopril treatment did not modify the calcium content, the internal and external diameters or the medial thickness of the aorta. Chronic ACEI did, however, increase the thickness of the medial elastic fibres (controls 3.55 ± 0.05 μm, low dose ACEI 4.05 ± 0.15 μm (P < 0.05), and high dose ACEI 4.18 ± 0.15 μm (P < 0.05)). 7 In conclusion, we would suggest that ACEI treatment with a low dose of lisinopril can decrease aortic stiffness via a pressure‐independent mechanism which possibly involves an effect of ACEI on elastic fibres.
doi_str_mv 10.1111/j.1476-5381.1994.tb14773.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1909964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76543595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5073-a3373f3f240771cd598cb029c28cc3ff04a87e534e5ec5294d67668ff30f626a3</originalsourceid><addsrcrecordid>eNqVkdGO1CAYhYnRrOPqI5g0xni1rVCgFC826kbdTTbRC70mlMIME0pXYMat8cJH8Bl9EulOM9FLuYH85zuHPzkAPEOwQvm83FaIsKakuEUV4pxUqcsDhqvbe2B1lO6DFYSQlQi17UPwKMYthDNGT8BJCyHBvF2BH1deBS2j7gsZkg5WuqK3MWkfbWedTVNhfb9TWe-mIm10If3ajne6__3zlxr9Xodk_brQ_vs06IxvsjON4axwNkPjTbDuLI8LP4bh4NzrIsgUH4MHRrqonyz3Kfjy_t3ni8vy-uOHq4s316WikOFSYsywwaYmkDGkespb1cGaq7pVChsDiWyZpphoqhWtOekb1jStMRiapm4kPgXnh9ybXTfoXmmfgnQiLzbIMIlRWvGv4u1GrMe9QBxy3pAc8GIJCOPXnY5JDDYq7Zz0etxFwRpKMOU0g68OoApjjEGb4ycIirk7sRVzQWIuSMzdiaU7cZvNT_9e82hdysr680WXUUlngvTKxiOGOUEtbTL2-oB9s05P_7GAePvp8u6J_wA-ALxx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76543595</pqid></control><display><type>article</type><title>Increased arterial distensibility induced by the angiotensin‐converting enzyme inhibitor, lisinopril, in normotensive rats</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Makki, Touria ; Talom, Rabelais Tatchum ; Niederhoffer, Nathalie ; Amin, Fatiha ; Tankosic, Pierre ; Mertès, Paul‐Michel ; Atkinson, Jeffrey</creator><creatorcontrib>Makki, Touria ; Talom, Rabelais Tatchum ; Niederhoffer, Nathalie ; Amin, Fatiha ; Tankosic, Pierre ; Mertès, Paul‐Michel ; Atkinson, Jeffrey</creatorcontrib><description>1 We investigated possible structural correlates of the beneficial effect of chronic angiotensin‐converting enzyme inhibition (ACEI) with lisinopril on the aortic distensibility of normotensive rats. 2 Experiments were performed in young (4‐month old), normotensive, Wistar rats which received lisinopril in their drinking water (0.9 or 9 mg kg−1 day−1) for 9 months. 3 Following ACEI treatment, rats were pithed and aortic pulse wave velocity was measured during the progressive rise in mean arterial blood pressure produced by i.v. infusion of the α1‐adrenoceptor agonist, phenylephrine. The slope of the regression line relating aortic pulse wave velocity to mean arterial blood pressure was taken as an index of aortic distensibility. Following this, the aorta was fixed in situ at a normotensive pressure level and histomorphometry was performed. We also measured the calcium content of the aortic wall by atomic absorption. 4 The lower dose of lisinopril failed to lower systolic arterial blood pressure (unanaesthetized rat) or mean arterial blood pressure (pithed rat). Chronic ACEI with the higher dose of lisinopril lowered both systolic arterial blood pressure (104 ± 6 mmHg, controls 133 ± 4 mmHg, unanaesthetized), and mean arterial blood pressure (27 ± 1 mmHg, controls 34 ± 2 mmHg, pithed). 5 Although the lower dose of lisinopril did not lower blood pressure, it did improve aortic distensibility as revealed by a fall in the slope relating aortic pulse wave velocity (Y) to mean arterial blood pressure (X). Values were 5.7 ± 0.7, 3.8 ± 0.6 and 2.7 ± 0.3 in controls, and in low and high ACEI groups, respectively. 6 Lisinopril treatment did not modify the calcium content, the internal and external diameters or the medial thickness of the aorta. Chronic ACEI did, however, increase the thickness of the medial elastic fibres (controls 3.55 ± 0.05 μm, low dose ACEI 4.05 ± 0.15 μm (P &lt; 0.05), and high dose ACEI 4.18 ± 0.15 μm (P &lt; 0.05)). 7 In conclusion, we would suggest that ACEI treatment with a low dose of lisinopril can decrease aortic stiffness via a pressure‐independent mechanism which possibly involves an effect of ACEI on elastic fibres.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1994.tb14773.x</identifier><identifier>PMID: 8004398</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>ACEI ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Aorta, Thoracic - drug effects ; Aorta, Thoracic - metabolism ; Aortic distensibility ; Biological and medical sciences ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Body Weight - drug effects ; Calcium - metabolism ; Cardiovascular system ; Decerebrate State - physiopathology ; Drinking - drug effects ; Eating - drug effects ; Elasticity - drug effects ; Heart - drug effects ; Heart Rate - drug effects ; Image Processing, Computer-Assisted ; In Vitro Techniques ; lisinopril ; Lisinopril - pharmacology ; Male ; Medical sciences ; Miscellaneous ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - metabolism ; normotensive rat ; Organ Size - drug effects ; Pharmacology. Drug treatments ; Phenylephrine - pharmacology ; pulse wave velocity ; Rats ; Rats, Wistar ; Renin - blood</subject><ispartof>British journal of pharmacology, 1994-02, Vol.111 (2), p.555-560</ispartof><rights>1994 British Pharmacological Society</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5073-a3373f3f240771cd598cb029c28cc3ff04a87e534e5ec5294d67668ff30f626a3</citedby><cites>FETCH-LOGICAL-c5073-a3373f3f240771cd598cb029c28cc3ff04a87e534e5ec5294d67668ff30f626a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1909964/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1909964/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3941856$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8004398$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Makki, Touria</creatorcontrib><creatorcontrib>Talom, Rabelais Tatchum</creatorcontrib><creatorcontrib>Niederhoffer, Nathalie</creatorcontrib><creatorcontrib>Amin, Fatiha</creatorcontrib><creatorcontrib>Tankosic, Pierre</creatorcontrib><creatorcontrib>Mertès, Paul‐Michel</creatorcontrib><creatorcontrib>Atkinson, Jeffrey</creatorcontrib><title>Increased arterial distensibility induced by the angiotensin‐converting enzyme inhibitor, lisinopril, in normotensive rats</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 We investigated possible structural correlates of the beneficial effect of chronic angiotensin‐converting enzyme inhibition (ACEI) with lisinopril on the aortic distensibility of normotensive rats. 2 Experiments were performed in young (4‐month old), normotensive, Wistar rats which received lisinopril in their drinking water (0.9 or 9 mg kg−1 day−1) for 9 months. 3 Following ACEI treatment, rats were pithed and aortic pulse wave velocity was measured during the progressive rise in mean arterial blood pressure produced by i.v. infusion of the α1‐adrenoceptor agonist, phenylephrine. The slope of the regression line relating aortic pulse wave velocity to mean arterial blood pressure was taken as an index of aortic distensibility. Following this, the aorta was fixed in situ at a normotensive pressure level and histomorphometry was performed. We also measured the calcium content of the aortic wall by atomic absorption. 4 The lower dose of lisinopril failed to lower systolic arterial blood pressure (unanaesthetized rat) or mean arterial blood pressure (pithed rat). Chronic ACEI with the higher dose of lisinopril lowered both systolic arterial blood pressure (104 ± 6 mmHg, controls 133 ± 4 mmHg, unanaesthetized), and mean arterial blood pressure (27 ± 1 mmHg, controls 34 ± 2 mmHg, pithed). 5 Although the lower dose of lisinopril did not lower blood pressure, it did improve aortic distensibility as revealed by a fall in the slope relating aortic pulse wave velocity (Y) to mean arterial blood pressure (X). Values were 5.7 ± 0.7, 3.8 ± 0.6 and 2.7 ± 0.3 in controls, and in low and high ACEI groups, respectively. 6 Lisinopril treatment did not modify the calcium content, the internal and external diameters or the medial thickness of the aorta. Chronic ACEI did, however, increase the thickness of the medial elastic fibres (controls 3.55 ± 0.05 μm, low dose ACEI 4.05 ± 0.15 μm (P &lt; 0.05), and high dose ACEI 4.18 ± 0.15 μm (P &lt; 0.05)). 7 In conclusion, we would suggest that ACEI treatment with a low dose of lisinopril can decrease aortic stiffness via a pressure‐independent mechanism which possibly involves an effect of ACEI on elastic fibres.</description><subject>ACEI</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Aorta, Thoracic - drug effects</subject><subject>Aorta, Thoracic - metabolism</subject><subject>Aortic distensibility</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Body Weight - drug effects</subject><subject>Calcium - metabolism</subject><subject>Cardiovascular system</subject><subject>Decerebrate State - physiopathology</subject><subject>Drinking - drug effects</subject><subject>Eating - drug effects</subject><subject>Elasticity - drug effects</subject><subject>Heart - drug effects</subject><subject>Heart Rate - drug effects</subject><subject>Image Processing, Computer-Assisted</subject><subject>In Vitro Techniques</subject><subject>lisinopril</subject><subject>Lisinopril - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>normotensive rat</subject><subject>Organ Size - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenylephrine - pharmacology</subject><subject>pulse wave velocity</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Renin - blood</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkdGO1CAYhYnRrOPqI5g0xni1rVCgFC826kbdTTbRC70mlMIME0pXYMat8cJH8Bl9EulOM9FLuYH85zuHPzkAPEOwQvm83FaIsKakuEUV4pxUqcsDhqvbe2B1lO6DFYSQlQi17UPwKMYthDNGT8BJCyHBvF2BH1deBS2j7gsZkg5WuqK3MWkfbWedTVNhfb9TWe-mIm10If3ajne6__3zlxr9Xodk_brQ_vs06IxvsjON4axwNkPjTbDuLI8LP4bh4NzrIsgUH4MHRrqonyz3Kfjy_t3ni8vy-uOHq4s316WikOFSYsywwaYmkDGkespb1cGaq7pVChsDiWyZpphoqhWtOekb1jStMRiapm4kPgXnh9ybXTfoXmmfgnQiLzbIMIlRWvGv4u1GrMe9QBxy3pAc8GIJCOPXnY5JDDYq7Zz0etxFwRpKMOU0g68OoApjjEGb4ycIirk7sRVzQWIuSMzdiaU7cZvNT_9e82hdysr680WXUUlngvTKxiOGOUEtbTL2-oB9s05P_7GAePvp8u6J_wA-ALxx</recordid><startdate>199402</startdate><enddate>199402</enddate><creator>Makki, Touria</creator><creator>Talom, Rabelais Tatchum</creator><creator>Niederhoffer, Nathalie</creator><creator>Amin, Fatiha</creator><creator>Tankosic, Pierre</creator><creator>Mertès, Paul‐Michel</creator><creator>Atkinson, Jeffrey</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199402</creationdate><title>Increased arterial distensibility induced by the angiotensin‐converting enzyme inhibitor, lisinopril, in normotensive rats</title><author>Makki, Touria ; Talom, Rabelais Tatchum ; Niederhoffer, Nathalie ; Amin, Fatiha ; Tankosic, Pierre ; Mertès, Paul‐Michel ; Atkinson, Jeffrey</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5073-a3373f3f240771cd598cb029c28cc3ff04a87e534e5ec5294d67668ff30f626a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>ACEI</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Aorta, Thoracic - drug effects</topic><topic>Aorta, Thoracic - metabolism</topic><topic>Aortic distensibility</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Body Weight - drug effects</topic><topic>Calcium - metabolism</topic><topic>Cardiovascular system</topic><topic>Decerebrate State - physiopathology</topic><topic>Drinking - drug effects</topic><topic>Eating - drug effects</topic><topic>Elasticity - drug effects</topic><topic>Heart - drug effects</topic><topic>Heart Rate - drug effects</topic><topic>Image Processing, Computer-Assisted</topic><topic>In Vitro Techniques</topic><topic>lisinopril</topic><topic>Lisinopril - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>normotensive rat</topic><topic>Organ Size - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenylephrine - pharmacology</topic><topic>pulse wave velocity</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Renin - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Makki, Touria</creatorcontrib><creatorcontrib>Talom, Rabelais Tatchum</creatorcontrib><creatorcontrib>Niederhoffer, Nathalie</creatorcontrib><creatorcontrib>Amin, Fatiha</creatorcontrib><creatorcontrib>Tankosic, Pierre</creatorcontrib><creatorcontrib>Mertès, Paul‐Michel</creatorcontrib><creatorcontrib>Atkinson, Jeffrey</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Makki, Touria</au><au>Talom, Rabelais Tatchum</au><au>Niederhoffer, Nathalie</au><au>Amin, Fatiha</au><au>Tankosic, Pierre</au><au>Mertès, Paul‐Michel</au><au>Atkinson, Jeffrey</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased arterial distensibility induced by the angiotensin‐converting enzyme inhibitor, lisinopril, in normotensive rats</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1994-02</date><risdate>1994</risdate><volume>111</volume><issue>2</issue><spage>555</spage><epage>560</epage><pages>555-560</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 We investigated possible structural correlates of the beneficial effect of chronic angiotensin‐converting enzyme inhibition (ACEI) with lisinopril on the aortic distensibility of normotensive rats. 2 Experiments were performed in young (4‐month old), normotensive, Wistar rats which received lisinopril in their drinking water (0.9 or 9 mg kg−1 day−1) for 9 months. 3 Following ACEI treatment, rats were pithed and aortic pulse wave velocity was measured during the progressive rise in mean arterial blood pressure produced by i.v. infusion of the α1‐adrenoceptor agonist, phenylephrine. The slope of the regression line relating aortic pulse wave velocity to mean arterial blood pressure was taken as an index of aortic distensibility. Following this, the aorta was fixed in situ at a normotensive pressure level and histomorphometry was performed. We also measured the calcium content of the aortic wall by atomic absorption. 4 The lower dose of lisinopril failed to lower systolic arterial blood pressure (unanaesthetized rat) or mean arterial blood pressure (pithed rat). Chronic ACEI with the higher dose of lisinopril lowered both systolic arterial blood pressure (104 ± 6 mmHg, controls 133 ± 4 mmHg, unanaesthetized), and mean arterial blood pressure (27 ± 1 mmHg, controls 34 ± 2 mmHg, pithed). 5 Although the lower dose of lisinopril did not lower blood pressure, it did improve aortic distensibility as revealed by a fall in the slope relating aortic pulse wave velocity (Y) to mean arterial blood pressure (X). Values were 5.7 ± 0.7, 3.8 ± 0.6 and 2.7 ± 0.3 in controls, and in low and high ACEI groups, respectively. 6 Lisinopril treatment did not modify the calcium content, the internal and external diameters or the medial thickness of the aorta. Chronic ACEI did, however, increase the thickness of the medial elastic fibres (controls 3.55 ± 0.05 μm, low dose ACEI 4.05 ± 0.15 μm (P &lt; 0.05), and high dose ACEI 4.18 ± 0.15 μm (P &lt; 0.05)). 7 In conclusion, we would suggest that ACEI treatment with a low dose of lisinopril can decrease aortic stiffness via a pressure‐independent mechanism which possibly involves an effect of ACEI on elastic fibres.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>8004398</pmid><doi>10.1111/j.1476-5381.1994.tb14773.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1994-02, Vol.111 (2), p.555-560
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1909964
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects ACEI
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Aorta, Thoracic - drug effects
Aorta, Thoracic - metabolism
Aortic distensibility
Biological and medical sciences
Blood Pressure - drug effects
Blood Pressure - physiology
Body Weight - drug effects
Calcium - metabolism
Cardiovascular system
Decerebrate State - physiopathology
Drinking - drug effects
Eating - drug effects
Elasticity - drug effects
Heart - drug effects
Heart Rate - drug effects
Image Processing, Computer-Assisted
In Vitro Techniques
lisinopril
Lisinopril - pharmacology
Male
Medical sciences
Miscellaneous
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - metabolism
normotensive rat
Organ Size - drug effects
Pharmacology. Drug treatments
Phenylephrine - pharmacology
pulse wave velocity
Rats
Rats, Wistar
Renin - blood
title Increased arterial distensibility induced by the angiotensin‐converting enzyme inhibitor, lisinopril, in normotensive rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T08%3A14%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20arterial%20distensibility%20induced%20by%20the%20angiotensin%E2%80%90converting%20enzyme%20inhibitor,%20lisinopril,%20in%20normotensive%20rats&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Makki,%20Touria&rft.date=1994-02&rft.volume=111&rft.issue=2&rft.spage=555&rft.epage=560&rft.pages=555-560&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1994.tb14773.x&rft_dat=%3Cproquest_pubme%3E76543595%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76543595&rft_id=info:pmid/8004398&rfr_iscdi=true